Glomerular haemodynamic profile of patients with Type 1 diabetes compared with healthy control subjects
Marko Škrtić(Ontario Institute for Cancer Research), David Z.I. Cherney(University Health Network), Gary K. Yang(University of Toronto), Paul S. F. Yip(Sunnybrook Health Science Centre), M. Silverman(Howard Hughes Medical Institute), Yuliya Lytvyn(University Health Network), Vesta Lai(University Health Network)
Cited by 19
Related Papers
Impact of diabetes on the effects of sodium glucose co-transporter-2 inhibitors on kidney outcomes: collaborative meta-analysis of large placebo-controlled trials
|The Lancet|2022|1k
Inhibition of Mitochondrial Translation as a Therapeutic Strategy for Human Acute Myeloid Leukemia
|Cancer Cell|2011|692
Sodium Glucose Cotransporter-2 Inhibition in Heart Failure
|Circulation|2017|470
Association between suicide reporting in the media and suicide: systematic review and meta-analysis
|BMJ|2020|366
Rationale and protocol of the Dapagliflozin And Prevention of Adverse outcomes in Chronic Kidney Disease (DAPA-CKD) randomized controlled trial
|Nephrology Dialysis Transplantation|2019|216